The biowarfare aspects of Q fever

Joshua D. Hartzell; Kerry Wilson; Larry I. Lutwick

The biowarfare aspects of Q fever

Joshua D. Hartzell, Kerry Wilson, Larry I. Lutwick^*

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.

Original language	English
Title of host publication	The Principles and Practice of Q Fever
Subtitle of host publication	The One Health Paradigm
Publisher	Nova Science Publishers, Inc.
Pages	289-299
Number of pages	11
ISBN (Electronic)	9781536108682
ISBN (Print)	9781536108514
State	Published - 1 Jan 2017
Externally published	Yes

Keywords

Antimicrobials
Biowarfare
Clinical symptoms
Immune response
US military's whitecoat program

Cite this

@inbook{a8c5c17c991b47cebff426caddf24756,

title = "The biowarfare aspects of Q fever",

abstract = "The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.",

keywords = "Antimicrobials, Biowarfare, Clinical symptoms, Immune response, US military's whitecoat program",

author = "Hartzell, {Joshua D.} and Kerry Wilson and Lutwick, {Larry I.}",

year = "2017",

month = jan,

day = "1",

language = "English",

isbn = "9781536108514",

pages = "289--299",

booktitle = "The Principles and Practice of Q Fever",

publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The biowarfare aspects of Q fever

AU - Hartzell, Joshua D.

AU - Wilson, Kerry

AU - Lutwick, Larry I.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.

AB - The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.

KW - Antimicrobials

KW - Biowarfare

KW - Clinical symptoms

KW - Immune response

KW - US military's whitecoat program

UR - http://www.scopus.com/inward/record.url?scp=85020324451&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85020324451

SN - 9781536108514

SP - 289

EP - 299

BT - The Principles and Practice of Q Fever

PB - Nova Science Publishers, Inc.

ER -

The biowarfare aspects of Q fever

Abstract

Keywords

Fingerprint

Cite this